Precision Medicine in Breast Cancer: From Basic Research to Clinical Practice
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 10 December 2024 | Viewed by 370
Special Issue Editors
2. David Geffen UCLA School of Medicine, Los Angeles, CA, USA
3. UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA
Interests: breast cancer; diabetes; metabolic syndrome; drug discovery; targeted therapy
Special Issues, Collections and Topics in MDPI journals
Interests: liquid biopsy; precision medicine; regenerative medicine; stem cells; drug discovery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Precision medicine (PM) has become the modern-day approach to breast cancer management.
Depending on the genetic variations, environmental factors, and lifestyle dynamics of each individual, PM aims to accomplish optimal therapeutic results, with reduced or no side effects, in a reasonable time and at an appropriate cost.
The approach of PM to disease management has been driven by the evolution of molecular biology and the opening of the human genome. PM is applied to most branches of medicine, including oncology, preventive medicine, and genetic and inherited disease, and there are no ethical dilemmas or moral challenges related to PM.
Dr. Yong Wu
Dr. John Yahya I. Elshimali
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- precision medicine
- germline and somatic mutations
- accurate therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
